Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TrivarX Limited (AU:TRI)
ASX:TRI
TrivarX Limited (TRI) Share Price & Analysis
4 Followers
TRI Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.02 - AU$0.04
Previous CloseAU$0.04
Volume20.32K
Average Volume (3M)1.59M
Market Cap
AU$16.00M
Enterprise ValueAU$15.03M
Total Cash (Recent Filing)AU$1.03M
Total Debt (Recent Filing)AU$66.42K
Price to Earnings (P/E)―
Beta-1.34
Next Earnings
Aug 30, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding207,529,690
10 Day Avg. Volume55,500
30 Day Avg. Volume1,587,485
Standard Deviation0.29
R-Squared0.07
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TrivarX Limited News
PremiumCompany Announcements
FIL Limited Boosts Stake in TrivarX Limited
PremiumCompany Announcements
TrivarX Director Bolsters Share Holdings
PremiumCompany Announcements
TrivarX Director’s Holdings Shift Notably
PremiumCompany Announcements
TrivarX Limited Plans New Share Quotation
PremiumCompany Announcements
TrivarX Limited Unveils New Options IssuePremiumCompany Announcements
TRIVARX LTD Issues 12 Million Unquoted Options
PremiumCompany Announcements
TrivarX Ltd Aims for ASX Securities QuotationPremiumCompany Announcements
TrivarX Limited Shareholders Approve Key ResolutionsOptions Prices
Currently, No data available
---
Ownership Overview
29.28% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
70.72% Public Companies and
Individual Investors
TRI FAQ
What was TrivarX Limited’s price range in the past 12 months?
TrivarX Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is TrivarX Limited’s market cap?
Currently, no data Available
When is TrivarX Limited’s upcoming earnings report date?
TrivarX Limited’s upcoming earnings report date is Aug 30, 2023 which is 328 days ago.
How were TrivarX Limited’s earnings last quarter?
TrivarX Limited released its earnings results on Feb 24, 2023. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is TrivarX Limited overvalued?
According to Wall Street analysts TrivarX Limited’s price is currently Overvalued.
Does TrivarX Limited pay dividends?
TrivarX Limited does not currently pay dividends.
What is TrivarX Limited’s EPS estimate?
TrivarX Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TrivarX Limited have?
TrivarX Limited has 457,038,700 shares outstanding.
What happened to TrivarX Limited’s price movement after its last earnings report?
TrivarX Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of TrivarX Limited?
Currently, no hedge funds are holding shares in AU:TRI
---
TrivarX Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-92.94%
12-Months-Change
Fundamentals
Return on Equity
-46.35%
Trailing 12-Months
Asset Growth
13.06%
Trailing 12-Months
Company Description
TrivarX Limited
Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development and early stage commercialisation of mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. It primarily serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets, being Australia and the United States.
---
Technical Analysis
---